The 1913 Nobel Prize in Physiology or Medicine was awarded to Charles Richet “in recognition of his work on anaphylaxis.”His research uncovered a paradoxical reaction in which the body’s defenses, instead of protecting it, could overreact with severe consequences. This discovery became a cornerstone of immunology and the study of allergic diseases.

In the late nineteenth and early twentieth centuries, medicine was advancing rapidly in understanding infections and immunity, but certain reactions remained mysterious. Doctors and researchers observed that both people and animals could suddenly develop difficulty breathing, collapse, or even fatal reactions after exposure to substances that had previously caused little harm. These responses were unpredictable and could not be explained by the existing understanding of how the immune system worked. Without understanding these reactions, treatments for toxins, vaccines, and other medical interventions carried significant risk, and there was no framework to prevent or manage severe allergic responses.

Early life

Charles Robert Richet was born on August 26, 1850, in Paris, France. He came from a medical family --his father, Alfred Richet, was a surgeon and professor. Besides immunology, he also studied subjects including physiology, psychology, and neuroscience. He studied medicine at the University of Paris, where he developed a fascination with physiology, toxins, and the body’s defensive mechanisms. Early in his career, Richet focused on understanding how animals responded to poisons and venoms, often observing that repeated exposure sometimes caused reactions far more severe than the first encounter.

These observations sparked his interest in systematically studying what he would later define as anaphylaxis. Richet spent years performing controlled experiments to uncover the principles behind these dangerous immune responses.

Richet’s major contribution

Richet’s breakthrough came in 1902 through experiments with marine toxins, in collaboration with French physiologist, Paul Portier. They exposed dogs to jellyfish and sea anemone venoms. While an initial dose often produced mild effects, subsequent exposures sometimes provoked violent reactions, including shock and death.

Richet documented these outcomes and recognised a distinct physiological phenomenon: anaphylaxis. He named it from the Greek “ana-” (opposite of) and “phylaxis” (protection), emphasising that the immune system could react in a harmful, rather than protective, way.

This discovery explained previously puzzling severe allergic reactions and became the first systematic description of hypersensitivity. Richet’s work showed that the immune system could overreact, providing the basis for understanding allergies, severe drug reactions, and other immune-mediated conditions. When Richet first described anaphylaxis in 1902, scientists largely believed the immune system only protected the body. His experiments revealed the opposite could also happen --the body’s own defenses could trigger sudden, deadly reactions after a second exposure to a substance.

Research contributions

Beyond describing anaphylaxis, Richet’s research laid the groundwork for safer medical practices. His findings informed the development of allergy testing, immunotherapy, and emergency interventions such as epinephrine treatment for life-threatening reactions. He also influenced the broader field of immunology, helping scientists understand that immune responses can be both protective and pathological.

Richet continued to study physiological reactions and toxins throughout his career, contributing to general knowledge of the nervous and circulatory systems. However, his work on anaphylaxis remained his best recognised achievement.

Impact on medicine

Charles Richet’s discovery fundamentally changed the understanding of the immune system. Today, anaphylaxis is recognised as a medical emergency, and protocols for its management directly reflect Richet’s insights. Treatments, preventive measures, and patient education in allergy care all trace back to his work.

His research also influenced the study of autoimmune diseases and other conditions in which the immune system causes harm. By revealing that the body’s defenses can sometimes overreact, Richet opened the door to safer therapies, vaccines, and clinical practices that anticipate and prevent harmful immune responses.

Charles Richet passed away on December 4, 1935, but his legacy endures. His experiments and documentation provided a framework for modern immunology, saving lives through a deeper understanding of allergic and hypersensitivity reactions.